MATINAS BIOPHARMA HOLDINGS I (MTNB) Stock Income Statement
USA - NYSEARCA:MTNB - US5768103039 - Common Stock
1.22 USD
+0.09 (+7.77%)
1.16 USD
-0.06 (-4.92%)
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 1.10M | 3.19M | 33.30K | 158.30K | |||
| Gross Premiums Earned | null | null | null | null | null | |||
| Loss Claims | null | null | null | null | null | |||
| Deferred Policy Acquisition Expense | null | null | null | null | null | |||
| Net Interest Income | null | null | null | null | null | |||
| Non Interest Income | null | null | null | null | null | |||
| Loan Loss Provision | null | null | null | null | null | |||
| Net Interest Income after Provision | null | null | null | null | null | |||
| Non Interest Expense | null | null | null | null | null | |||
| Minority Interest Expense | null | null | null | null | null | |||
| Cost Of Goods | null | null | null | null | null | |||
| Gross Profit | null | null | null | null | null | |||
| Operating Expenses | 20.16M | 24.86M | 27.78M | 24.77M | 24.36M | |||
| Research and Development | 11.43M | 14.49M | 16.68M | 14.58M | 14.36M | |||
| Selling, General, and Administrative Expenses | 8.73M | 10.37M | 11.10M | 10.18M | 10.01M | |||
| Operating Income | -20.16M | -23.77M | -24.59M | -24.73M | -24.21M | |||
| Interest Income/Expense | null | null | null | null | 686.40K | |||
| Other Income/Expense | 262.00K | 340.00K | 102.00K | 122.90K | null | |||
| Non Recurring Items | -4.43M | 484.00K | 3.49M | 1.33M | 1.07M | |||
| Income Before Taxes | -24.33M | -22.94M | -21.00M | -23.28M | -22.45M | |||
| Income Tax | -80.00K | null | null | null | null | |||
| Net Income | -24.25M | -22.94M | -21.00M | -23.68M | -23.24M | |||
| EBITDA | -19.79M | -23.37M | -24.23M | -24.45M | -23.92M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -4.9839 | -5.2797 | -4.8422 | -5.6331 | -0.118 | |||
| Non GAAP EPS | -4.17 | -5.5 | -5.5 | -5.5 | -6 | |||
| Statistics | ||||||||
| Profit Margin | N/A | -2093.25% | -658.63% | -71108.71% | -14681.17% | |||
| Operating Profit Margin | N/A | -2168.43% | -771.33% | -74278.68% | -15291.60% | |||
All data in USD